Brugada Phenocopy Induced by BRAF and MEK Inhibitors in a Lung Adenocarcinoma
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16533 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Leonardo Portolan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Proto-Oncogene Proteins B-raf, Adenocarcinoma of Lung, Protein Kinase Inhibitors. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Management of patients with drug‐induced type 1 Brugada pattern is complex and controversial. We report the case of a 66‐year‐old man affected by metastatic lung adenocarcinoma with type 1 Brugada phenocopy at electrocardiogram (ECG) after initiation of an oncological therapy with BRAF and MEK inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
ORCID-Profile: Leonardo Portolan, Alessandro Ruzzarin, Giacomo Mugnai
Zitieren
APA
Portolan, L., Ruzzarin, A., Vassanelli, F., Ribichini, F., & Mugnai, G. (2025). Brugada Phenocopy Induced by BRAF and MEK Inhibitors in a Lung Adenocarcinoma. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16533
Vancouver
Portolan L, Ruzzarin A, Vassanelli F, Ribichini F, Mugnai G. Brugada Phenocopy Induced by BRAF and MEK Inhibitors in a Lung Adenocarcinoma. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16533
BibTeX
@article{Portolan2025,
author = {Portolan, Leonardo and Ruzzarin, Alessandro and Vassanelli, Francesca and Ribichini, Flavio and Mugnai, Giacomo},
title = {Brugada Phenocopy Induced by BRAF and MEK Inhibitors in a Lung Adenocarcinoma},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16533}
}
EUVIMED